There is no single “best” weight loss pill for everyone, but the most effective options available right now are prescription medications that mimic a gut hormone called GLP-1. In clinical trials, the top-performing drug, tirzepatide (brand name Zepbound), reduced body weight by about 21% over 72 weeks, while semaglutide (Wegovy) produced roughly 15% loss over a similar period. Which one works best for you depends on your health profile, your tolerance for side effects, and whether you can access and afford the medication long-term.
FDA-Approved Prescription Options
The FDA has approved several prescription medications specifically for weight loss in adults. The newest and most effective belong to a class called GLP-1 receptor agonists, which work by mimicking a hormone your body naturally releases after eating. This hormone slows digestion, reduces appetite, and signals to your brain that you’re full. The current FDA-approved options include:
- Zepbound (tirzepatide): An injectable that targets two gut hormones simultaneously. It produced the highest weight loss in clinical trials, with nearly one-third of participants losing at least 25% of their body weight.
- Wegovy (semaglutide): Available as a weekly injection or, as of late 2025, an oral tablet. A higher-dose injectable version (Wegovy HD) was approved in March 2026. About 16% of trial participants on semaglutide lost 25% or more of their body weight.
- Foundayo (orforglipron): Approved in April 2026, this is a once-daily oral pill that works through the same GLP-1 pathway but doesn’t require injection or the strict dosing routine of earlier oral formulations.
- Saxenda (liraglutide): A daily GLP-1 injection that predates Wegovy and Zepbound. It produces more modest weight loss and has largely been overtaken by the newer options.
- Contrave (bupropion/naltrexone): A twice-daily pill combining two older drugs that work on brain chemistry to reduce cravings and appetite. Weight loss is typically more modest than with GLP-1 drugs.
- Qsymia (phentermine/topiramate): A daily pill that suppresses appetite through a different mechanism. It’s been available since 2012 and remains an option for people who can’t use or access GLP-1 medications.
How the Top Medications Compare
A head-to-head clinical trial led by researchers at Cornell’s Weill Cornell Medicine found that Zepbound clearly outperformed Wegovy. Participants on the maximum dose of tirzepatide lost 20.9% of their body weight over 72 weeks, compared to 14.9% with semaglutide over 68 weeks. That gap matters: the difference between losing 40 pounds and losing 55 pounds for someone who weighs 260.
The older prescription pills, Contrave and Qsymia, typically produce 5% to 10% weight loss. That’s clinically meaningful and enough to improve blood pressure, blood sugar, and cholesterol, but it’s noticeably less than what GLP-1 medications deliver. For people who don’t qualify for or can’t tolerate the newer drugs, these remain reasonable choices.
Injectable vs. Oral: Which Works Better
GLP-1 medications were originally developed as injections because the active proteins get broken down by stomach acid before they can work if swallowed. Newer oral formulations use special coatings or different molecular structures to survive digestion, but there’s a tradeoff. Injectable versions generally deliver higher, more consistent doses and produce greater weight loss in clinical trials.
The oral versions come with practical demands. Earlier oral semaglutide, for example, must be taken on an empty stomach with only a small sip of water, and you need to wait at least 30 minutes before eating or drinking anything else. The newer oral option, Foundayo (orforglipron), is designed to be less finicky, which is one reason it generated significant interest after approval. If needles are a dealbreaker for you, oral options are viable, but you may see somewhat less dramatic results.
Side Effects to Expect
Gastrointestinal symptoms are by far the most common side effects of GLP-1 medications. Nausea, vomiting, diarrhea, and constipation affect the majority of users, especially during the first few weeks and each time the dose increases. In a large real-world study of over 7,600 patients on semaglutide, about 77% reported at least one side effect, with roughly 73% experiencing mild symptoms. Around 6% reported severe side effects, most of which were gastrointestinal.
These symptoms tend to improve as your body adjusts. Doctors typically start with a low dose and increase gradually over several months to minimize discomfort. Beyond gut issues, GLP-1 medications carry some less common but more serious risks: gallbladder problems, acute kidney injury, and, in rare cases, pancreatitis. Semaglutide is also contraindicated for anyone with a personal or family history of a specific type of thyroid cancer called medullary thyroid carcinoma, though current evidence hasn’t established that the drug actually causes it.
Contrave and Qsymia have different side effect profiles. Contrave can cause headaches, insomnia, and elevated blood pressure. Qsymia may cause tingling in the hands and feet, dry mouth, and changes in taste. Both carry their own contraindications, so your doctor’s recommendation will depend on your full medical picture.
Who Qualifies for Prescription Medication
According to the National Institute of Diabetes and Digestive and Kidney Diseases, doctors can prescribe weight loss medication if you’re an adult with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition like high blood pressure, type 2 diabetes, or high cholesterol. These thresholds apply across all FDA-approved weight loss drugs.
Having a qualifying BMI alone doesn’t guarantee your insurance will cover the cost, but it’s the medical starting point for the conversation with your doctor.
Cost and Insurance Coverage
Cost is the biggest practical barrier for most people. GLP-1 medications can run $1,300 or more per month without insurance. Coverage varies widely and is often inconsistent. Some employers specifically exclude GLP-1 drugs from their health plans. Many insurers require prior authorization and documentation of obesity-related health problems before approving coverage. A high BMI alone may not be enough to get your claim approved.
Medicare currently cannot cover weight loss medications by law, which leaves a large portion of older adults without a coverage pathway. Manufacturer discount programs exist but still leave many people paying hundreds out of pocket each month. The older medications, Contrave and Qsymia, tend to be significantly cheaper, especially in generic form, which makes them worth considering if the newer drugs are financially out of reach.
Why Long-Term Use Matters
One critical thing to understand before starting any weight loss medication: these drugs work only as long as you take them. Between 50% and 75% of people who start GLP-1 medications stop within the first year, and the weight typically comes back. A 2023 survey found that while 45% of U.S. adults were interested in trying these drugs, that number dropped to just 14% when people learned they’d likely regain the weight after stopping.
Obesity is increasingly treated as a chronic condition, similar to high blood pressure or high cholesterol. Just as you wouldn’t expect your blood pressure to stay low after stopping your medication, the appetite and metabolic changes driven by weight loss drugs reverse when you stop taking them. If you’re considering these medications, plan for the possibility of long-term or indefinite use, and factor that into both the financial and medical decision.
Why Over-the-Counter Supplements Are Different
Over-the-counter “weight loss pills” sold as dietary supplements occupy a completely different category from the prescription drugs above. Under federal law, supplement manufacturers are responsible for evaluating the safety and labeling of their own products before selling them. The FDA only steps in after a product reaches the market, and only if it’s found to be adulterated or mislabeled. This means no supplement has gone through the rigorous clinical trials required of prescription medications, and none have proven they produce meaningful, sustained weight loss in large studies.
Popular supplements like green tea extract, garcinia cambogia, and conjugated linoleic acid have been studied individually, but results are consistently modest at best, often amounting to a pound or two over several months. Some supplements have been found to contain undisclosed pharmaceutical ingredients, including stimulants and laxatives, that pose real health risks. If a supplement claims results comparable to prescription GLP-1 drugs, that claim has no clinical backing.